New Delhi, India

Parven Kumar Luthra

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Thane, IN (2021)
  • New Delhi, IN (2021 - 2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Parven Kumar Luthra: A Pioneer in Pharmaceutical Innovations

Introduction

Parven Kumar Luthra, an accomplished inventor based in New Delhi, India, has made significant contributions to the field of pharmaceuticals, holding an impressive seven patents. His innovative work focuses on developing novel compounds and processes that enhance the efficacy and safety of medical treatments.

Latest Patents

Among his latest inventions, Luthra has developed solid-state forms of baloxavir marboxil. This patent encompasses the preparation processes, pharmaceutical compositions, and methods of use, aiming to improve the therapeutic applications of this antiviral agent. Additionally, he has disclosed a process for the preparation of Remimazolam and its solid-state forms. This work involves novel processes and intermediates for producing short-acting benzodiazepines, along with pharmaceutical formulations and methods of use, highlighting his significant impact on anesthesia and sedation practices.

Career Highlights

Parven Kumar Luthra has worked with esteemed organizations such as Assia Chemical Industries Ltd. and Watson Laboratories Inc. His experience in these reputable companies has provided a robust foundation for his inventive endeavors in the pharmaceutical industry.

Collaborations

Throughout his career, Luthra has collaborated with talented professionals, including Anantha Rajmohan Muthusamy and Amit Singh. These collaborations have further enriched his work, fostering innovation in the development of pharmaceutical solutions.

Conclusion

Parven Kumar Luthra exemplifies the spirit of innovation in the pharmaceutical field. With his seven patents and ongoing contributions to medical science, he continues to pave the way for advancements that could benefit patient care and treatment methodologies globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…